TPTX - Turning Point Therapeutics EPS beats by $0.12 beats on revenue November, 12 2020 04:43 PM Turning Point Therapeutics Inc. Turning Point Therapeutics (TPTX): Q3 GAAP EPS of -$0.42 beats by $0.12.Revenue of $25M beats by $12.5M.Press Release For further details see: Turning Point Therapeutics EPS beats by $0.12, beats on revenue